Illumina

Gene sequencing company Illumina sells cancer test developer – The New York Times

Illumina, the leading maker of gene sequencing machines, said Sunday it would sell Grail, a cancer test developer it bought for $7.1 billion in 2021. The move came two days after Illumina lost its case in a federal appeals court that largely upheld a Federal Trade Commission decision that Illumina should terminate its contract with … [Read more…]

Stocks Make Biggest Moves Midday: Groupon, Wynn Resorts, Plug Power, Illumina and More

Check out the companies making headlines in midday trading. Groupon – Shares plunged 39.5%, a day after the online marketplace company reported third-quarter revenue and global gross billings that fell short of expectations. In addition, the company approved a fully underwritten rights offering to shareholders of $80 million. Wynn Resorts – The resort and casino … [Read more…]